Literature DB >> 15361862

The nisin-lipid II complex reveals a pyrophosphate cage that provides a blueprint for novel antibiotics.

Shang-Te D Hsu1, Eefjan Breukink, Eugene Tischenko, Mandy A G Lutters, Ben de Kruijff, Robert Kaptein, Alexandre M J J Bonvin, Nico A J van Nuland.   

Abstract

The emerging antibiotics-resistance problem has underlined the urgent need for novel antimicrobial agents. Lantibiotics (lanthionine-containing antibiotics) are promising candidates to alleviate this problem. Nisin, a member of this family, has a unique pore-forming activity against bacteria. It binds to lipid II, the essential precursor of cell wall synthesis. As a result, the membrane permeabilization activity of nisin is increased by three orders of magnitude. Here we report the solution structure of the complex of nisin and lipid II. The structure shows a novel lipid II-binding motif in which the pyrophosphate moiety of lipid II is primarily coordinated by the N-terminal backbone amides of nisin via intermolecular hydrogen bonds. This cage structure provides a rationale for the conservation of the lanthionine rings among several lipid II-binding lantibiotics. The structure of the pyrophosphate cage offers a template for structure-based design of novel antibiotics.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15361862     DOI: 10.1038/nsmb830

Source DB:  PubMed          Journal:  Nat Struct Mol Biol        ISSN: 1545-9985            Impact factor:   15.369


  168 in total

1.  Cell Wall-active Bacteriocins and Their Applications Beyond Antibiotic Activity.

Authors:  Clara Roces; Ana Rodríguez; Beatriz Martínez
Journal:  Probiotics Antimicrob Proteins       Date:  2012-12       Impact factor: 4.609

2.  Overexpression, purification and crystallization of the response regulator NsrR involved in nisin resistance.

Authors:  Sakshi Khosa; Astrid Hoeppner; Diana Kleinschrodt; Sander H J Smits
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2015-09-23       Impact factor: 1.056

3.  Crystal Structure of NisI in a Lipid-Free Form, the Nisin Immunity Protein, from Lactococcus lactis.

Authors:  Jin Hee Jeong; Sung Chul Ha
Journal:  Antimicrob Agents Chemother       Date:  2018-02-23       Impact factor: 5.191

4.  Insights into in vivo activities of lantibiotics from gallidermin and epidermin mode-of-action studies.

Authors:  Raquel Regina Bonelli; Tanja Schneider; Hans-Georg Sahl; Imke Wiedemann
Journal:  Antimicrob Agents Chemother       Date:  2006-04       Impact factor: 5.191

Review 5.  Rings, radicals, and regeneration: the early years of a bioorganic laboratory.

Authors:  Wilfred A van der Donk
Journal:  J Org Chem       Date:  2006-12-22       Impact factor: 4.354

6.  Specificity of Subtilin-Mediated Activation of Histidine Kinase SpaK.

Authors:  Christoph Geiger; Tobias Spieß; Sophie Marianne Korn; Peter Kötter; Karl-Dieter Entian
Journal:  Appl Environ Microbiol       Date:  2017-08-31       Impact factor: 4.792

7.  Molecular mechanism of target recognition by subtilin, a class I lanthionine antibiotic.

Authors:  Judicaël Parisot; Sarah Carey; Eefjan Breukink; Weng C Chan; Arjan Narbad; Boyan Bonev
Journal:  Antimicrob Agents Chemother       Date:  2007-11-12       Impact factor: 5.191

8.  Efficacious Analogs of the Lantibiotic Mutacin 1140 against a Systemic Methicillin-Resistant Staphylococcus aureus Infection.

Authors:  Mengxin Geng; Akshaya Ravichandran; Jerome Escano; Leif Smith
Journal:  Antimicrob Agents Chemother       Date:  2018-11-26       Impact factor: 5.191

Review 9.  Lactic Acid Bacteria (LAB) and Their Bacteriocins as Alternative Biotechnological Tools to Control Listeria monocytogenes Biofilms in Food Processing Facilities.

Authors:  Anderson C Camargo; Svetoslav D Todorov; N E Chihib; D Drider; Luís A Nero
Journal:  Mol Biotechnol       Date:  2018-09       Impact factor: 2.695

10.  The First structure of a lantibiotic immunity protein, SpaI from Bacillus subtilis, reveals a novel fold.

Authors:  Nina A Christ; Sophie Bochmann; Daniel Gottstein; Elke Duchardt-Ferner; Ute A Hellmich; Stefanie Düsterhus; Peter Kötter; Peter Güntert; Karl-Dieter Entian; Jens Wöhnert
Journal:  J Biol Chem       Date:  2012-08-17       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.